Cytokine--chemokine and apoptotic signatures in patients with hepatitis C. (Q38481426)

3 September 2017

Cytokine--chemokine and apoptotic signatures in patients with hepatitis C. (English)

1 reference

3 September 2017

0 references

3

Patrick Marcellin

1 reference

3 September 2017

Manuela G Neuman

1

1 reference

3 September 2017

Jean-Pierre Benhamou

2

1 reference

3 September 2017

Dominique Valla

4

1 reference

3 September 2017

Izabella M Malkiewicz

5

1 reference

3 September 2017

Gad G Katz

6

1 reference

3 September 2017

Cristhian Trepo

7

1 reference

3 September 2017

Marc Bourliere

8

1 reference

3 September 2017

Ross G Cameron

9

1 reference

3 September 2017

Lawrence Cohen

10

1 reference

3 September 2017

Mary Morgan

11

1 reference

3 September 2017

Hemda Schmilovitz-Weiss

12

1 reference

3 September 2017

Ziv Ben-Ari

13

1 reference

3 September 2017

1 March 2007

1 reference

3 September 2017

Translational Research

1 reference

3 September 2017

149

1 reference

3 September 2017

126-136

1 reference

3 September 2017

3

1 reference

Effects of immunosuppression and organ transplantation on the natural history and immunopathogenesis of hepatitis C virus infection

3 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.002

Immune-mediated liver damage in chronic hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.002

Serum levels of cytokines in chronic liver diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.002

Cytokines in viral hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.002

Immunopathogenesis of hepatitis C viral infection: Th1/Th2 responses and the role of cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.002

Inflammatory markers in chronic hepatitis C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.002

Role of transforming growth factor beta in human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.002

Apoptosis in hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.002

Chemokines--chemotactic cytokines that mediate inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.002

Properties of pro-inflammatory cell type-specific leukocyte chemotactic cytokines, interleukin 8 (IL-8) and monocyte chemotactic and activating factor (MCAF)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.002

Predictors of sustained response to alpha interferon therapy in chronic hepatitis C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.002

Tumor necrosis factor-alpha and transforming growth factor-beta reflect severity of liver damage in primary biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.002

Kinetics of serum cytokines reflect changes in the severity of chronic hepatitis C presenting minimal fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.002

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.002

Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.002

Endotoxemia in liver disease--time for re-appraisal?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.002

Circulating interleukin-1 and tumor necrosis factor antagonists in liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.002

Interleukin-6 production by peripheral blood monocytes in patients with chronic liver disease and acute viral hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.002

Interleukin-18 and interleukin-12 synergize to stimulate the production of vascular permeability factor by T lymphocytes in normal subjects and in patients with minimal-change nephrotic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.002

Human chemokines: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.002

Chemokines: what chemokine is that?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.002

Through the looking glass: the diverse in vivo activities of chemokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.002

Immunopathology of hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.002

Expression of C-C chemokines is associated with portal and periportal inflammation in the liver of patients with chronic hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.002

Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.002

The central executioners of apoptosis: caspases or mitochondria?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.002

The prodomain of caspase-1 enhances Fas-mediated apoptosis through facilitation of caspase-8 activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.002

Cytochrome c: can't live with it--can't live without it.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.002

Apoptosis in diseases of the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.002

Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.002

Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.002

The interplay between primary and secondary cytokines. Cytokines involved in the regulation of monocyte recruitment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.002

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRSL.2006.11.002

1 reference

3 September 2017

1 reference